<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title40.html">
                                    Title 40
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/40CFR725.html">Part 725
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 725.205  Persons who may report under this subpart.
                            </h3>
                            <p class="depth1"><em>(a)</em> Commercial research and development activities involving new  microorganisms or significant new uses of microorganisms are subject to  reporting under this part unless they qualify for an exemption under  this part.</p><p class="depth1"><em>(b)</em> Commercial purposes for research and development means that the  activities are conducted with the purpose of obtaining an immediate or  eventual commercial advantage for the researcher and would include:</p><p class="depth2"><em>(1)</em> All research and development activities which are funded  directly, in whole or in part, by a commercial entity regardless of who  is actually conducting the research. Indications that the research and  development activities are funded directly, in whole or in part, may  include, but are not limited to:</p><p class="depth3"><em>(i)</em> Situations in which a commercial entity contracts directly with  a university or researcher; or</p><p class="depth3"><em>(ii)</em> Situations in which a commercial entity gives a conditional  grant where the commercial entity holds patent   rights, or establishes a joint venture where the commercial entity holds  patent or licensing rights; or</p><p class="depth3"><em>(iii)</em> Any other situation in which the commercial entity intends to  obtain an immediate or eventual commercial advantage for the commercial  entity and/or the researcher.</p><p class="depth2"><em>(2)</em> Research and development activities that are not funded directly  by a commercial entity, if the researcher intends to obtain an immediate  or eventual commercial advantage. Indications that the researcher  intends to obtain an immediate or eventual commercial advantage may  include, but are not limited to:</p><p class="depth3"><em>(i)</em> The research is directed toward developing a commercially viable  improvement of a product already on the market; or</p><p class="depth3"><em>(ii)</em> The researcher has sought or is seeking commercial funding for  the purpose of developing a commercial application; or</p><p class="depth3"><em>(iii)</em> The researcher or university has sought or is seeking a patent  to protect a commercial application which the research is developing; or</p><p class="depth3"><em>(iv)</em> Other evidence that the researcher is aware of a commercial  application for the research and has directed the research toward  developing that application.</p><p class="depth1"><em>(c)</em> Certain research and development activities involving  microorganisms subject to jurisdiction under the Act are exempt from  reporting under this part. A person conducting research and development  activities which meet the conditions for the exemptions described in  Sec. Sec. 725.232, 725.234, or 725.238 is exempt from TERA reporting  under this subpart.</p><p class="depth1"><em>(d)</em> A microorganism is not exempt from reporting under subpart D of  this part if any amount of the microorganism, including as part of a  mixture, is processed, distributed in commerce, or used, for any  commercial purpose other than research and development.</p><p class="depth1"><em>(e)</em> Quantities of the inactivated microorganism, or mixtures or  articles containing the inactivated microorganism, remaining after  completion of research and development activities may be disposed of as  a waste in accordance with applicable Federal, State, and local  regulations.</p><p class="depth1"><em>(f)</em> A person who manufactures, imports, or processes a microorganism  solely for research and development is not required to comply with the  requirements of this section if:</p><p class="depth2"><em>(1)</em> The person is manufacturing a microbial pesticide identified in  Sec. 172.45(c), or</p><p class="depth2"><em>(2)</em> The person is manufacturing a microbial pesticide for which an  Experimental Use Permit is required, pursuant to Sec. 172.3; or</p><p class="depth2"><em>(3)</em> The person is manufacturing a microbial pesticide for which a  notification or an Experimental Use Permit is not required to be  submitted.</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
